# Sandostatin

NDC: 0078-0182
Generic name: octreotide acetate
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 19881021

FDA application: NDA019667

## Active ingredients

- OCTREOTIDE ACETATE: 500 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0182"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0182
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39